Generic Name: Dolutegravir
Brand Names: Tivicay
Dolutegravir is an integrase strand transfer inhibitor (INSTI) used as part of HIV combination therapy.
Dolutegravir is prescribed for:
High barrier to resistance among integrase inhibitors.
Common side effects:
Serious side effects:
Dolutegravir is a second-generation integrase inhibitor with a high barrier to resistance.
Can be taken once daily in most patients, with twice daily dosing needed only with certain drug interactions.
Initial concerns about neural tube defects in pregnancy have been largely resolved with more data.
For more information, see MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Dolutegravir? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.